EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two‐sample Mendelian randomization analysis of European and East Asian populations

Jinsheng Huang, Xujia Li, Jicheng Hong, Lingli Huang iD, Qi Jiang, Shunqi Guo, Yuming Rong, Guifang Guo iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.6057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Jinsheng Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: VIP Department, Sun Yat-sen University Cancer Center, Guangzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Inflammatory Bowel Diseases, Liver Neoplasms, Pancreatic Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Both inflammatory bowel disease (IBD) and hepato‐pancreato‐biliary cancers (HPBC) have been established to cause a huge socioeconomic burden. Epidemiological studies have revealed a close association between IBD and HPBC.

Methods

Herein, we utilized inverse‐variance weighting to conduct a two‐sample Mendelian randomization analysis. We sought to investigate the link between various subtypes of IBD and HPBC. To ensure the accuracy and consistency of our findings, we conducted heterogeneity tests, gene pleiotropy tests, and sensitivity analyses.

Results

Compared to the general population, IBD patients in Europe exhibited a 1.22‐fold increased incidence of pancreatic cancer (PC) with a 95% confidence interval (CI) of 1.0022–1.4888 ( p = 0.0475). We also found a 1.14‐fold increased incidence of PC in Crohn's disease (CD) patients with (95% CI: 1.0017–1.3073, p = 0.0472). In the East Asian population, the incidence of hepatocellular carcinoma (HCC) was 1.28‐fold higher (95% CI = 1.0709–1.5244, p = 0.0065) in IBD patients than in the general population. Additionally, ulcerative colitis (UC) patients displayed 1.12‐fold (95% CI: 1.1466–1.3334, p < 0.0001) and 1.31‐fold (95% CI: 1.0983–1.5641, p = 0.0027) increased incidences of HCC and cholangiocarcinoma (CCA), respectively. Finally, the incidence of PC was 1.19‐fold higher in CD patients than in the general population (95% CI = 1.0741–1.3132, p = 0.0008).

Conclusion

Our study validated that IBD is a risk factor for HPBC. This causal relationship exhibited significant heterogeneity in different European and East Asian populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularInflammatory Bowel DiseasesLiver NeoplasmsPancreatic NeoplasmsBiliary Tract NeoplasmsHumansBile Duct NeoplasmsBile Ducts, IntrahepaticCrohn DiseaseEast Asian PeopleMendelian Randomization AnalysisEuropean People

Stichwörter der Autor:innen

Crohn's diseaseMendelian randomizationhepatobiliary pancreatic cancerinflammatory bowel diseaseulcerative colitis

Autor:innen und Institutionen

  • VIP Department, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Department of Emergency, Shantou Central Hospital, Shantou, China.

ORCID-Profile: Lingli Huang, Guifang Guo

Förderung

  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Huang, J., Li, X., Hong, J., Huang, L., Jiang, Q., Guo, S., Rong, Y., & Guo, G. (2023). Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two‐sample Mendelian randomization analysis of European and East Asian populations. Cancer Medicine. https://doi.org/10.1002/cam4.6057

Vancouver

Huang J, Li X, Hong J, Huang L, Jiang Q, Guo S, et al. Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two‐sample Mendelian randomization analysis of European and East Asian populations. Cancer Medicine. 2023. doi:10.1002/cam4.6057

BibTeX
@article{Huang2023,
  author = {Huang, Jinsheng and Li, Xujia and Hong, Jicheng and Huang, Lingli and Jiang, Qi and Guo, Shunqi and Rong, Yuming and Guo, Guifang},
  title = {Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two‐sample Mendelian randomization analysis of European and East Asian populations},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6057}
}
Kostenlos starten →